ID: ALA189700

Max Phase: Preclinical

Molecular Formula: C32H29N3O8S2

Molecular Weight: 647.73

Molecule Type: Small molecule

Representations

Canonical SMILES:  CC(C)[C@H](NS(=O)(=O)c1ccc(-c2ccc(NC(=O)c3cc4cc(NS(=O)(=O)c5ccccc5)ccc4o3)cc2)cc1)C(=O)O

Standard InChI:  InChI=1S/C32H29N3O8S2/c1-20(2)30(32(37)38)35-45(41,42)27-15-10-22(11-16-27)21-8-12-24(13-9-21)33-31(36)29-19-23-18-25(14-17-28(23)43-29)34-44(39,40)26-6-4-3-5-7-26/h3-20,30,34-35H,1-2H3,(H,33,36)(H,37,38)/t30-/m0/s1

Standard InChI Key:  GGJDCLDUCIBTBH-PMERELPUSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 647.73

Molecular Weight (Monoisotopic): 647.1396

AlogP: 5.54

#Rotatable Bonds: 11

Polar Surface Area: 171.88

Molecular Species: ACID

HBA: 7

HBD: 4

#RO5 Violations: 2

HBA (Lipinski): 11

HBD (Lipinski): 4

#RO5 Violations (Lipinski): 3

CX Acidic pKa: 3.33

CX Basic pKa:

CX LogP: 5.04

CX LogD: 1.49

Aromatic Rings: 5

Heavy Atoms: 45

QED Weighted: 0.14

Np Likeness Score: -1.09

References

1. Wu J, Rush TS, Hotchandani R, Du X, Geck M, Collins E, Xu ZB, Skotnicki J, Levin JI, Lovering FE..  (2005)  Identification of potent and selective MMP-13 inhibitors.,  15  (18): [PMID:16005220] [10.1016/j.bmcl.2005.06.019]

Source

Source(1):

• Scientific Literature